Maxcyte (MXCT) Assets Average (2021 - 2026)

Maxcyte (MXCT) has 6 years of Assets Average data on file, last reported at $198.5 million in Q1 2026.

• On a quarterly basis, Assets Average fell 15.43% year-over-year to $198.5 million in Q1 2026; TTM through Mar 2026 was $198.5 million, a 15.43% decrease from a year earlier, with the FY2025 full-year figure at $221.0 million, down 12.95% from the prior year.
• Assets Average for Q1 2026 stood at $198.5 million, down from $208.0 million in the prior quarter.
• Over the last five years, Assets Average for MXCT reached as high as $290.4 million in Q2 2022 and fell as low as $198.5 million in Q1 2026.
• Historically, Assets Average has averaged $255.5 million across 5 years, with a median of $263.1 million in 2024.
• Across the five-year window, Assets Average soared 55.38% in 2022 and dropped 15.43% in 2026, its largest moves.
• Year by year, Assets Average stood at $286.5 million in 2022, then retreated by 6.64% to $267.5 million in 2023, then retreated by 8.77% to $244.0 million in 2024, then dropped by 14.77% to $208.0 million in 2025, then fell by 4.57% to $198.5 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $198.5 million in Q1 2026, $208.0 million in Q4 2025, and $216.6 million in Q3 2025.